Exploring P-Glycoprotein Substrate Access  by Domicevica, Laura & Biggin, Philip C.
146a Sunday, February 8, 2015725-Pos Board B505
Multiscale QM/MM Simulations of ATP Hydrolysis Mechanism in ABC-
Transporters
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Adenosine triphosphate (ATP) binding cassette (ABC) transporters are ubiqui-
tous molecular motor proteins that translocate various substrates across cell
membranes at the expense of ATP hydrolysis. Although it is known that
nucleotide binding domains in ABC-transporters contain a collection of char-
acteristic sequence motifs, the precise mechanism under which ATP is hydro-
lyzed in these systems remains unknown. By using multiscale combined
quantum mechanical and molecular mechanical (QM/MM) free energy simula-
tions, we examined several possible ATP hydrolysis mechanisms in members
of ABC-transporters. Our results reveal how the active site residues may partic-
ipate in the catalytic mechanism and how protein dynamics may contribute to
catalysis.
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Multidrug resistance (MDR), a phenomenon in which cells become resistant to
a number of drugs, is a growing obstacle for treatment of cancer and bacterial
infections. A group of membrane transporters, known as MDR efflux pumps
that bind to a wide range of foreign molecules and pump them out of the
cell, are suspected to be the main contributors to MDR. P-glycoprotein
(Pgp), which is the most well studied MDR efflux pump, has a critical role
in the distribution of drugs in the body. As a result, screening the interactions
between this protein and candidate drugs has recently become a required step in
the FDA approval process. Biophysical characterization of Pgp and its transport
activity may provide key information for the design and development of effec-
tive therapeutics. Giant unilamellar vesicles (GUV) are excellent models for
natural cell membranes and present appealing platforms for biophysical studies
of Pgp under well-defined conditions. Here, we reconstitute Pgp from Chinese
hamster ovary B30 cells in giant unilamellar vesicles and investigate its
ATPase activity as well as its transport activity.
In this study, we applied small proteoliposomes with reconstituted Pgp for
electroformation of Pgp-containing giant vesicles via our recently reported
technique of hydrogel-assisted electroformation. These electroformed giant
vesicles were characterized using fluorescence microscopy, immunohisto-
chemistry, and ATPase assays. Fluorescence immunostaining confirmed the
presence of Pgp in the membrane of GUVs. ATPase assay demonstrated that
Pgp in GUVs retained its ATPase activity upon electroformtion. The specific
ATPase activity of Pgp in GUVs was about 640 nmol/mg,min, comparable
to that of this protein in small proteoliposomes, ~660 nmol/mg,min. Moreover,
we are investigating the transport activity of Pgp in these giant liposomes using
fluorescence microscopy. The present study may provide valuable insight to the
function of this MDR efflux pump.
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P-glycoprotein (P-gp), an ATP Binding Cassette transporter family membrane
protein, extrudes mainly hydrophobic substrates in an ATP hydrolysis-
dependant manner. Structurally, P-gp consists of two transmembrane domains
(TMD) each comprised of 6 a-helices that together form the drug binding site,
and two nucleotide binding domains (NBD) that via ATP binding and hydroly-
sis provide the energy for the conformational changes necessary to drive drug
translocation.
Due to the wide variety of substrates it extrudes, P-gp is one of the main causes
of multidrug resistance in cancer and other diseases. As multidrug resistance
becomes an ever increasingly important issue, drug development is dependant
on knowing what constitutes the difference between a substrate and a non-
substrate of P-gp. Although the chemical structure is likely to play a role in
recognition within the binding site, it is equally important to understand how
access to the binding site is controlled. Therefore more information about
way in which substrates access the binding site is of key interest.
In the absence of a human P-gp crystal structure, several human homology
models were made from both eukaryotic and bacterial homologue crystal struc-
tures. The models were assessed for structural stability and conformational dy-
namics using molecular dynamics (MD) simulations. Following analysis, thehomology model from the C. elegans template was chosen as the model for
steered MD calculations to investigate possible substrate access pathways.
The results, when combined with bilayer localisation NMR experiments and
MD simulations, give novel insights into the factors that govern P-gp substrate
specificity.
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ABC transporters are widely distributed amongst kingdoms and are responsible
for nutrient transport across cellular membranes. Certain soil bacteria contain a
higher than average percentage of ABC transporters, representing 40-70% of
encoded transporters. While studies of SBPs have indicated that permeases
can interact with multiple SBPs with varying affinity and specificity, limited in-
formation exists regarding permease specificity for ATPases. The potential for
permeases to interact with multiple ATPases was suggested given the high ge-
netic redundancy of homologous types of ABC transporters in plant growth
promoting bacteria (PGPB). Genomic analyses of four Pseudomas fluorescens
strains identified a tractable set of ABC-type amino acid importers with high
sequence similarity to the structurally characterized E. coli methionine
importer MetNI, sharing the presence of a C-terminal C2 regulatory domain
on the ATPase. This domain inhibits methionine uptake by preventing ATP hy-
drolysis when intracellular methionine is bound.
Using a dual-expression-vector strategy, both native complexes and ‘hybrid’
complexes were stably isolated. Native complexes utilize permease and
ATPase components from an individual operon whereas hybrid complexes
partner a permease domain from one operon with an ATPase domain from
another. Interestingly, three target ATPases from strain PF-5 were able to
form stable complexes with a single PF-5 permease target, suggesting this
strain has high potential for hybrid interactions. These PF-5 hybrid complexes
are shown to be dimers by gel filtration and functional by ATPase assays.
The transinhibition mechanism of the C2 domain was also investigated,
showing that D- and L-methionine differentially inhibit ATP hydrolysis of
PF-5 hybrid complexes. Initial studies of SBPs associated with these complexes
show a correlation between SBP ligands and compounds allosterically inhibit-
ing ATPases. The ability for crosstalk could be especially significant for PGPB,
allowing them to provide rapid and specific nutrient exchange with symbiotic
species.
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We investigate the structure formed byof phospholamban (PLB) bound to the
sarcoplasmic reticulum (SR) Ca2þ-ATPase (SERCA) using site-directed spin
labeling. SERCA is a 994 residue transmembrane protein that helps control
Ca2þ concentration in the SR relative to the cytoplasm in order to facilitate
muscle relaxation. PLB is a 52 residue regulatory muscle protein found in car-
diac muscle which, upon binding, has been shown to inhibit SERCA activity.
However, phosphorylation of PLB at Ser-16 partially relieves this inhibition
while still maintaining a combined structureconserving the complex. The struc-
tural mechanism behind this relief of inhibition is largely unknown. Using EPR
accessibility measurements, we have shown that phosphorylation of PLB at
Ser-16 alters the binding interface between its transmembrane helix and the
PLB binding groove on SERCA, likely breaking the interactions that lead to
inhibition.
730-Pos Board B510
Mapping of Sarcolipin Conformational States along the Enzymatic
Pathway of SERCA
Alysha A. Dicke1, Kaustubh R. Mote2, Gianluigi Veglia1.
1BMBB, University of Minnesota, Minneapolis, MN, USA, 2TIFR Center for
Interdisciplinary Sciences, Narsinghi, India.
Sarcolipin (SLN), a 31 amino acid transmembrane peptide, binds to the
Sarco(endo)plasmic Reticulum Ca2þ ATPase (SERCA) decreasing its
apparent Ca2þ affinity. SERCA pumps Ca2þ from the cytoplasm of muscle
cells into the sarcoplasmic reticulum (SR) using energy derived from ATP hy-
drolysis. This re-establishes the Ca2þ gradients needed for normal muscle
function. Phosphorylation of SLN relieves the inhibition of SERCA and
may be involved in the beta-adrenergic response. Although a significant
amount is known about SERCA, and many of the conformations throughout
its transport cycle have been crystallized, the mechanism of how SLN de-
creases SERCA’s Ca2þ affinity and alters the coupling between ATP
